Insider: Nolan Sean P. Chief Executive Officer - Taysha Gene Therapies, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,908,257 | 1,535,545 | 4,443,802 |
| Value | $12,709,083.09 | $6,710,331.65 | $19,419,414.74 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/26/2026 | DDS | 41,312 | Direct | COM | $4.61 | $190,448.32 | 2,908,257 |
| 01/23/2026 | DDS | 136,789 | Direct | COM | $4.75 | $649,747.75 | 2,949,569 |
| 08/16/2023 | AAP | 444,444 | Indirect | COM | $0.90 | $399,999.60 | 1,535,545 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research